We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dutch Appellate Court Upholds Lipitor Patent

Law360 (February 21, 2008, 12:00 AM EST) -- An appellate court in the Netherlands has upheld a patent covering a key component of Pfizer Inc.’s blockbuster cholesterol drug Lipitor, the pharmaceutical company said Thursday.

The decision by the Court of Appeal of The Hague in the Netherlands will delay the launch of a generic version of Lipitor by Indian generic maker Ranbaxy Laboratories Ltd. until Pfizer’s patent expires in November 2011.

Pfizer said the patent, EP 247,633, is a basic patent covering atorvastatin, the active ingredient in Lipitor.

“Today’s decision is another affirmation of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.